172. Clinical Outcomes of Over 500 Lung Transplants Using Ex Vivo Lung Perfusion: A Large Volume Single Center Retrospective Analysis

*Isabelle Opitz Invited Discussant
University Hospital Zurich
Zurich, MA 
Switzerland
 - Contact Me

Professor Isabelle Opitz is Director of the Department of Thoracic Surgery, Chair of the Lung Cancer Center, and Member of both the Robotic and the Transplant Center Board at University Hospital Zurich, Switzerland. She is Professor/Ordinaria for Thoracic Surgery at the University of Zurich. Her clinical areas of expertise are the surgical treatment of lung cancer, pleural mesothelioma, chronic thromboembolic pulmonary hypertension, and lung transplantation.

She has received several national and international awards for her research. She is Past President and Past Treasurer of the European Society of Thoracic Surgeons. For this society, she also works as a member of the Steering Committee of the Working Group Robotic, organizing the newly founded ESTS Robotic School and the Clinical Trials Working Group, implementing the Thoracic European Surgical Trials (TEST) Clinical Trials Platform.She is International Director of the American Association for Thoracic Surgeryand serves in their Thoracic Education Committee and the Thoracic Clinical Practice Standards Committee. She will be co-chair of IASLC World Conference on Lung Cancer 2025 and is a member of the ESMO 2025 scientific committee. 

Aadil Ali Abstract Presenter
Latner Thoracic Surgery Research Laboratories, Toronto General Hospital Research Institute
Toronto, ON 
Canada
 - Contact Me

Aadil Ali completed his PhD at the University of Toronto under the direct supervision of Dr. Marcelo Cypel. His research focused on bringing forward static cold storage at 10 degrees celcius as a new standard of care. Aadil has published in numerous high impact journals and has recieved various awards for his work.

Sunday, May 7, 2023: 5:17 PM - 5:32 PM
15 Minutes 
Los Angeles Convention Center 
Room: 408A 

Presentation Duration

7 minute presentation; 7 minute discussion 

View Submission